An unusual cause of graft loss in pediatric liver transplant recipient—Fasciola hepatica

Fascioliasis is caused by the trematode liver fluke Fasciola hepatica. Humans are accidental hosts getting infected after ingesting contaminated plants or water. 90 million people in 75 nations are at risk of infection with F hepatica. Immunosuppressed patients are higher risk of acquiring infection...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric transplantation 2019-09, Vol.23 (6), p.e13521-n/a
Main Authors: Kelgeri, Chaya, Valamparampil, Joseph, Shanmugam, Naresh, Srinivas Reddy, Mettu, Swaminathan, Subramanian, Rela, Mohamed
Format: Article
Language:English
Subjects:
Bile
Diagnosis
Eggs
Enzyme-linked immunosorbent assay
Fasciola hepatica
graft loss
Hemagglutination
Immunoelectrophoresis
Immunofluorescence
Indirect hemagglutination
Infections
Liver
Liver transplantation
Liver transplants
Morbidity
Parasites
parasitic infection
Patients
Pediatrics
Serology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fascioliasis is caused by the trematode liver fluke Fasciola hepatica. Humans are accidental hosts getting infected after ingesting contaminated plants or water. 90 million people in 75 nations are at risk of infection with F hepatica. Immunosuppressed patients are higher risk of acquiring infection and may present with atypical manifestations. Patients can present with hepatic involvement, biliary features or a combination of both. Confirmation of the diagnosis is by demonstration of live parasites or eggs in bile or feces, serology (immunoelectrophoresis, indirect immunofluorescence, indirect hemagglutination), ELISA, typical imaging findings or a combination of any of the above. The drug of choice for treatment is triclabendazole. Fascioliasis should always be considered as a possibility in post‐LT patients with findings of hepatobiliary disorder from endemic areas. Unfamiliarity with this infection in non‐endemic areas often eludes prompt diagnosis thereby increasing the morbidity. We report the first case of fascioliasis in a pediatric liver transplant recipient leading to graft loss and mortality.
ISSN:1397-3142
1399-3046
DOI:10.1111/petr.13521